✨ Free AI Report
IRadimed Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research IRadimed Corporation
Company Research

IRadimed Corporation: Business Overview, Financials & Competitive Analysis

IRadimed develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The...

Analyst-debate audio for IRadimed Corporation

AskCyborg analysts argue the bull and bear cases for IRadimed Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
8/ 10Strong

Cyborg Score thesis

Market-leading MRI-compatible medical devices with 17 consecutive quarters of record revenue, unique competitive moat, and...

Read the full analyst-debate transcript →
Industry Medical Devices - MRI-Compatible Equipment & Infusion Therapy Systems
2 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest IRadimed Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

IRadimed Corporation Overview

Pro stress-test →

IRadimed develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. The company serves hospitals, acute care facilities, and outpatient imaging centers.

Strategic Profile

Pro stress-test →

The company highlighted its 17 consecutive quarters of record revenue and cited sustained financial health and strong stock performance as drivers of the recognition. The device maintains Iradimed's unique position as the world's only provider of non-magnetic MRI infusion pumps since 2005. This replacement strategy is a key factor in IRADIMED's projection of breaking through the $100 million revenue run rate in 2026. Domestic pump device revenue is expected to grow from an estimated $28 million in 2025 to nearly $50 million in 2026, driven by these upgrades.

Competitive Landscape

Pro stress-test →

IRadimed maintains a unique market position as the sole manufacturer of non-magnetic MRI-compatible infusion pumps since 2005. The specialized nature of MRI-safe medical devices creates high barriers to entry, with few direct competitors in this niche. The company competes primarily with traditional IV pump manufacturers on functionality and safety integration, but its MRI compatibility focus provides differentiation in the critical imaging/acute care segment.

Industry Context

IRadimed Corporation operates in Medical Devices - MRI-Compatible Equipment & Infusion Therapy Systems.

Key facts

Founded: 1992 · Headquarters: Winter Springs, United States · Employees: null · Revenue: $82.5M-$83.5M (FY 2025 guidance) · Market cap: $1.17B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on IRadimed Corporation.

  • Limited commercial shipments of the next‑gen 3870 pump are expected in Dec 2025 with full U.S. rollout in Q1 2026.
  • In the U.S. alone, there are over 6,200 MRI IV pump channels (3860 models) that are 5 years or older and are candidates for replacement. The company aims to add approximately 1,000 replacement channels annually in 2026, increasing this number to over 2,000 and growing in subsequent years.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Insider director share sale activity; Q1 2026 earnings guidance issued at $0.44-0.48 EPS
  • November 2025Named to TIME's America's Growth Leaders for 2026 (79th place); announced special $0.50/share dividend
  • +2 moreTrack every material event for IRadimed Corporation as it happens. Explore monitoring →
Get alerted when IRadimed Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Traditional IV Infusion PumpsNon-MRI-compatible infusion pump systems→Patient Monitoring SystemsMRI-compatible monitoring alternatives (limited infusion capability)→

Compare IRadimed Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

IRadimed Corporation operates in Medical Devices - MRI-Compatible Equipment & Infusion Therapy Systems. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - MRI-Compatible Equipment & Infusion Therapy Systems research →
NEW · MCP server

Ask your AI assistant about IRadimed Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare IRadimed Corporation and its top competitor on Cyborg Score”
“What did IRadimed Corporation do this quarter?”
“Is IRadimed Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does IRadimed Corporation do?+
IRadimed develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The...
What is IRadimed Corporation's Cyborg Score?+
IRadimed Corporation has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are IRadimed Corporation's main competitors?+
Named competitors include Traditional IV Infusion Pumps, Patient Monitoring Systems. The full competitive landscape is in the AskCyborg report.
How can I get the full IRadimed Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the IRadimed Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track IRadimed Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.